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Cholinergic signaling modulates synaptic responses and influences cognition. In this issue of Neuron, two
groups (Buchanan et al. andGiessel and Sabatini) present evidence that cholinergic signaling enhances post-
synaptic responses in CA1 neurons by decreasing synaptic SK channel activity. However, they come to
different conclusions about the protein kinases involved in this process.A role for acetylcholine (ACh) in cognitive
processes was demonstrated more than
50 years ago, even before ACh was
revealed as a bona fide neurotransmitter.
The physiological actions of ACh are initi-
ated by binding to two distinct classes
of plasma membrane receptors: nicotinic
ACh receptors (nAChRs) and muscarinic
ACh receptors (mAChRs). The nAChRs
are ionotropic ACh-gated cation channels
while the mAChRs are G protein-coupled
receptors.
Cholinergic fibers originating in the
basal forebrain ramify throughout the
neocortex, hippocampus, basolateral
amygdala, and olfactory bulb. Agonists
of mAChRs, or cholinesterase inhibitors
that elevate ACh levels in the brain,
increase attention and improve cognitive
functions. In humans as well as in rodent
models, blockade of mAChRs by drugs
such as scopalamine produces an array
of profound deficits in attention process-
ing, memory acquisition, and memory
consolidation (Hasselmo and McGaughy,
2004). In addition, mAChRs are thera-
peutic targets in various diseases. For
example, there is a selective loss of
cholinergic neurons in Alzheimer disease,
and systemic administration of cholines-
terase inhibitors improves cognitive func-
tion. Antimuscarinic agents are also
widely used for the treatment of Parkinson
disease.
Hippocampal CA1 neurons receive
cholinergic input onto basal dendrites in
stratum oriens. Cholinergic neurotrans-
mission underlies a slow synaptic poten-tial that is due to suppression of K+
conductances (Nicoll, 1985). In addition,
stimulation of cholinergic fibers facilitates
population spikes, and activation of
mACh receptors increases synaptic
transmission at Shaffer collateral-CA1
synapses (Markram and Segal, 1990b).
Activation of mACh receptors also modu-
lates the induction of long-term potentia-
tion (LTP) that is thought to represent
one of the cellular processes underlying
learning and memory. Cholinergic stimu-
lation elicits an oscillatory theta rhythm
in the hippocampus that occurs during
periods of learning (Winson, 1978), and
during these oscillations, synapses can
be modified by an otherwise ineffective
stimulation. Indeed, results from in vivo
recordings as well as in vitro brain slice
studies suggest that ACh enhances LTP
(Ovsepian et al., 2004; Shinoe et al.,
2005). Of the five mAChR subtypes,
a great deal of attention has been focused
on M1 receptors. These are the most
abundant in the hippocampal formation,
and they are especially enriched in area
CA1. M1 AChR null mice have significant
impairments in working memory and
consolidation (Anagnostaras et al., 2003),
and stimulation of cholinergic fibers does
not enhance LTP.
At the cellular level ACh (Markram and
Segal, 1990a) or M1 agonists (Sur et al.,
2003) increase, while M1 antagonists
decrease (Marino et al., 1998), NMDA
receptor currents in CA1 neurons. M1-
type mACh receptors couple to Gq,
increase phosphatylinositol turnover,Neuron 68,activate phospholipase C, mobilize Ca
from intracellular stores, and activate
protein kinase C. However, the pathway
between M1 activation and increased
currents through NMDARs has remained
unknown. Nevertheless, activation of M1
receptors and subsequent potentiation
of NMDAR currents could provide a
crucial mechanism by which cholinergic
input to the hippocampus influences
cognitive function.
Several voltage- and Ca2+-gated ion
channels affect excitatory synaptic
responses. Among these are SK2 chan-
nels, K+ channels that are activated solely
by intracellular Ca2+ ions and are selec-
tively blocked by the peptide toxin, apa-
min (Kohler et al., 1996). In CA1 neurons,
SK2 channels are expressed in the
postsynaptic density of dendritic spines,
close to NMDARs (Lin et al., 2008),
where they are activated by synaptically
driven Ca2+ influx through NMDARs or
CaV2.3 channels (Bloodgood and Saba-
tini, 2007; Ngo-Anh et al., 2005). Synaptic
SK2 channel activity repolarizes the spine
membrane, reducing the EPSP, attenu-
ating the unblock of NMDARs by external
Mg2+ ions, and thereby reducing the spine
Ca2+ transient (Ngo-Anh et al., 2005) that
is crucial to the induction of synaptic plas-
ticity. Thus synaptic SK2 channels serve
as an endogenous ‘‘brake’’ for NMDARs.
Indeed, blocking SK2 channels with apa-
min facilitates the induction of synaptic
plasticity, and transgenic mice that over-
express SK2 have impaired LTP. Consis-
tent with this synaptic function, systemicDecember 9, 2010 ª2010 Elsevier Inc. 809
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campus-dependent memory encoding
(Stackman et al., 2002), and SK2-
overexpressing mice are severely im-
paired in hippocampus-dependent learn-
ing (Stackman et al., 2002; Hammond
et al., 2006).
Ca2+ gating of SK2 channels is en-
dowed by coassembly of the pore-form-
ing channel subunits with calmodulin
(CaM), which is constitutively bound to
the intracellular C terminus of each SK
subunit (Xia et al., 1998). When Ca2+ ions
bind to the N-lobe E-F hands of CaM,
the channels open, and Ca2+ unbinding
closes the channels. Thus to a first
approximation, the Ca2+ sensitivity of
SK2 channels reflects the Ca2+ affinity of
the E-F hands in CaM; under resting
conditions, [Ca2+]in 50 nM, the channels
are closed and become fully active when
[Ca2+]in reaches 1 mM. Additionally coas-
sembled with SK2 channels are protein
kinase CK2 and protein phosphatase 2A
(PP2A). In complex with the SK2 channels
CK2 phosphorylates SK2-associated
CaM, resulting in a reduced Ca2+ sensi-
tivity, while dephosphorylation resets the
Ca2+ sensitivity of the channels. Impor-
tantly, the activities of CK2 and PP2A
are strictly state dependent. CK2 only
phosphorylates closed SK2 channels,
while PP2A acts on open channels (Allen
et al., 2007). Therefore, SK2 channels in
spines do not have an absolute Ca2+
sensitivity, but rather their Ca2+ sensitivity
is itself activity dependent.
In this issue of Neuron, two groups,
Giessel andSabatini (2010) andBuchanan
et al. (2010), report that inCA1neuronsM1
AChR activation does not work through
direct modulation of NMDARs. Rather,
M1 activation decreases SK channel
activity, thereby increasing synaptic
responses. While both groups agree that
SK channels are the culprits, they come
to different conclusions about just how
SK channel activity is decreased by M1
receptor activation. Giessel and Sabatini
conclude that M1 activation works
through CK2 to decrease the Ca2+ sensi-
tivity of the SK channels while Buchanan
et al. conclude that PKC, and not CK2,
is the signal transducer between M1
receptors and SK channels.
Giessel and Sabatini uncaged gluta-
mate onto single spines on apical
dendrites of CA1 neurons loaded with810 Neuron 68, December 9, 2010 ª2010 Elsa Ca2+ indicator and measured the result-
ing EPSPs (uEPSP) and spine Ca2+ tran-
sients. In the presence of the mACh
agonist oxotremorine-m (oxo-m), uEPSPs
and spine Ca2+ transients were increased,
but not when oxo-m was applied in the
presence of the M1 antagonist, Mtx-7.
Testing whether oxo-m affected AMPAR
or NMDAR currents, or Ca2+ transients,
ruled out a direct effect of M1 activation
on ionotropic glutamate receptors.
However, blocking SK channels or
CaV2.3 channels occluded the effects of
M1 activation, implicating either direct
inhibition of SK channels, or perhaps
a reduction of the Ca2+ that fuels their
activity, in mediating the postsynaptic
effects of M1 activation. Previous studies
had found that mAChR agonists enhance
CaV2.3 currents, which would enhance,
not decrease, coupled SK channel
activity. However, SNX-482-sensitive,
CaV2.3-mediated spine Ca2+ transients
measured using somatic voltage steps
were unaffected by M1 activation, ruling
out modulation of CaV2.3 channels by
M1 activation—though the Ca2+ influx
through CaV2.3 channels makes up
25% of the Ca2+ influx under these
conditions. This process of elimination
focused attention on SK channels as
a possible target for mAChR signaling.
A population of SK channels in CA1
neurons can be activated by Ca2+ influx
evoked by somatic step depolarization
and is revealed as an outward current
upon repolarization. Indeed, the SK
currents activated by this method were
virtually occluded by oxo-m. For testing
whether the Ca2+ sensitivity of these SK
channels was altered by oxo-m, SK chan-
nels were activated by increasing dura-
tions of laser pulses in cells filled with a
photosensitive Ca2+ chelator, NP-EGTA,
an elegant way to construct a relative
Ca2+ dose-response relationship for the
SK channels. The results showed that
oxo-m reduced the Ca2+ sensitivity of
the SK channels. But does this occur in
spines, and if so, does the decreased
Ca2+ sensitivity require CK2 activity?
These questions were addressed by
using weak synaptic stimulations to acti-
vate only spine SK channels. In contrast
to control conditions, apamin had no
effect on EPSPs when applied after
oxo-m. Finally, the CK2 antagonist, TBB,
prevented the oxo-m induced increasesevier Inc.of uEPSPs and spine Ca2+ transients
leading the authors to conclude that M1
AChR activation increases CK2 activity
that reduces SK2 Ca2+ sensitivity.
Buchanan et al. took advantage of a
recently discoveredM1-selective agonist,
77-LH-28-1. Previously, this group had
shown that a theta burst pairing (TBP)
protocol that pairs subthreshold EPSPs
evoked by Shaffer collateral stimulations
with back-propagating action potentials
fails to induce LTP in CA1 neurons.
However, in the presence of 77-LH-28-1,
or by shocking cholinergic fibers in
stratum oriens prior to TBP, robust
pathway-specific LTP was induced.
Given that previous reports had shown
that mAChR activation increases currents
through NMDARs (see above), the effects
of muscarinic agonists on NMDAR
currents were examined. They found
no effect when measured at +40 mV
(or at 60 mV in low external Mg2+)
where Mg2+ block is not substantial.
However, at60 mV and with Mg2+ block
present, muscarinic activation increased
EPSCNMDA. Therefore, the effects of
mAChR activation on NMDAR currents
are indirect and require the voltage-
dependent block by external Mg2+. In
addition, 77-LH-28-1 increased the dura-
tion and decay time of EPSPs by an
apparent increase of the NMDA compo-
nent, as the NMDAR antagonist, D-AP5,
reversed the effects. These results are
similar to those from Giessel and Sabatini
using single-spine responses to gluta-
mate uncaging, though in contrast Gies-
sel and Sabatini report an increase in
EPSP amplitude, consistent with previous
reports (Ngo-Anh et al., 2005), in addition
to increases in half width. The results can
be understood in terms of SK channel
effects. Since synaptic SK channel
activity decreases the NMDA component
of EPSPs (Ngo-Anh et al., 2005), apamin,
which blocks SK channels and in-
creases EPSPs and the NMDA compo-
nent in a D-AP5-sensitive manner, was
applied and increased the duration of
5-summated EPSPs, and occluded the
effects of 77-LH-28-1. Thus, both groups
show that apamin occludes the effects of
M1 activation. Buchanan et al. also found
that 77-LH-28-1 suppressed SK currents
measured in voltage-clamp, again, similar
to the results from Giessel and Sabatini.
Knowing that M1 receptors activate PKC
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Buchanan et al. tested the effects of
PKC inhibitors and found that they
blocked the effects of 77-LH-28-1 on SK
tail currents and on summated EPSPs,
thus concluding that PKC mediates the
effects of M1 activation. Nevertheless,
aware that SK-associated CK2 activity
can suppress SK channel activity,
Buchanan et al. tested the effects of
CK2 inhibitors, similar to the experiments
performed by Giessel and Sabatini. They
found that CK2 inhibitors did not affect
the suppression of SK tail currents by
77-LH-28-1 but did prolong summated
EPSPs. However, this effect was appar-
ently independent of the effect of 77-LH-
28-1 and was apamin insensitive, compli-
cations that were not encountered by
Giessel and Sabatini.
Therefore, the results from both of
these papers support the conclusion
that the effects of M1 mAChR activation
on synaptic transmission are mediated
by a protein kinase-dependent reduction
in SK channel activity. However, they
reach different conclusions as to the
identity of the kinase and perhaps the
cellular mechanisms engaged by each
kinase: results from Giessel and Sabatini
support CK2 while Buchanan et al. favor
PKC. One possibility is that both groups
are correct and SK channel activity can
be downregulated subsequent to M1
activation by either CK2 or PKC. Giessel
and Sabatini did not test for PKC while
Buchanan et al. tested for CK2 but
encountered difficulties that suggested
that CK2 was not involved but precluded
firm conclusions concerning the role
of CK2.
If CK2 activity is involved in the
suppression of SK channel activity subse-
quent to M1 activation, it raises an inter-
esting question. As discussed above,
CK2 and PP2A are coassembled with
the SK channels and CK2 only phosphor-
ylates SK-associated CaM when the
channels are closed, due to the state-
dependent disposition of K121 in the SK
channel N-terminal domain. Thus, whenthe channels open upon synaptic activity
and Ca2+ influx, PP2A should dephos-
phorylate SK-associated CaM and in-
crease the Ca2+ sensitivity. Therefore, it
seems that upon M1 activation either
SK2-associated CK2 activity is rendered
state independent and active or modula-
tion is actually occurring through de-
creased PP2A activity so that even with
the channels open, SK-associated CaM
remains phosphorylated.
If PKC is involved inmAChR-dependent
suppression of SK channel activity, what
is the actual target of PKC? For CK2 there
is a molecular framework to understand
how a CK2-dependent process may
suppress SK channel activity. However,
direct PKC regulation of SK channels
has not yet been reported, although there
are several consensus PKC substrates on
SK2 channels. If PKC is directly phos-
phorylating SK channels, then what is
the consequence? It is possible that
PKC phosphorylation shifts the Ca2+
sensitivity of the channels, similar to the
effects of CK2, but other scenarios are
clearly possible, including effects on traf-
ficking such as surface expression or
proximity to their Ca2+ sources.
Regardless of whether it is CK2/PP2A
or PKC, or possibly both, the M1 signaling
pathway originates in spines on basal
dendrites in stratum oriens and affects
SK channels in spines on the apical
dendrites in stratum radiatum. Interest-
ingly, both groups show that upon M1
activation, SK channels that are activated
by step depolarization in somatic voltage
clamp are suppressed. As this probably
represents more than just synaptic SK2
channels, is PKC or CK2/PP2A activity
globally affected by M1 activation, or is
specificity for SK channels engendered
by an as yet unknownmechanism? Future
work will undoubtedly clarify the roles of
PKC and CK2/PP2A in M1 signaling
through SK channels. Nonetheless, the
results from both groups focus attention
on synaptic SK channels and their roles
in shaping neurotransmission, synaptic
plasticity, and cognition.Neuron 68,REFERENCES
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